Alcon (ALC) Competitors $87.21 -0.14 (-0.16%) Closing price 03:58 PM EasternExtended Trading$87.23 +0.02 (+0.03%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALC vs. DXCM, HCA, THC, EHC, UHS, ENSG, ACHC, SEM, BKD, and USPHShould you be buying Alcon stock or one of its competitors? The main competitors of Alcon include DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), Encompass Health (EHC), Universal Health Services (UHS), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Select Medical (SEM), Brookdale Senior Living (BKD), and U.S. Physical Therapy (USPH). These companies are all part of the "medical" sector. Alcon vs. Its Competitors DexCom HCA Healthcare Tenet Healthcare Encompass Health Universal Health Services The Ensign Group Acadia Healthcare Select Medical Brookdale Senior Living U.S. Physical Therapy Alcon (NYSE:ALC) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Do analysts rate ALC or DXCM? Alcon presently has a consensus target price of $106.13, suggesting a potential upside of 21.69%. DexCom has a consensus target price of $99.60, suggesting a potential upside of 18.53%. Given Alcon's higher possible upside, equities research analysts clearly believe Alcon is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alcon 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80DexCom 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 2.91 Do institutionals & insiders hold more shares of ALC or DXCM? 53.9% of Alcon shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, ALC or DXCM? Alcon has higher revenue and earnings than DexCom. Alcon is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlcon$9.91B4.34$1.02B$2.2538.76DexCom$4.03B8.17$576.20M$1.3462.71 Is ALC or DXCM more profitable? DexCom has a net margin of 12.90% compared to Alcon's net margin of 11.28%. DexCom's return on equity of 30.05% beat Alcon's return on equity.Company Net Margins Return on Equity Return on Assets Alcon11.28% 6.95% 4.92% DexCom 12.90%30.05%10.00% Does the media prefer ALC or DXCM? In the previous week, DexCom had 23 more articles in the media than Alcon. MarketBeat recorded 25 mentions for DexCom and 2 mentions for Alcon. DexCom's average media sentiment score of 0.92 beat Alcon's score of 0.12 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DexCom 12 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, ALC or DXCM? Alcon has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. SummaryDexCom beats Alcon on 13 of the 17 factors compared between the two stocks. Get Alcon News Delivered to You Automatically Sign up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALC vs. The Competition Export to ExcelMetricAlconMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$43.08B$6.53B$5.48B$20.69BDividend YieldN/A1.33%4.00%3.65%P/E Ratio38.7625.3728.1127.47Price / Sales4.3455.23420.8156.24Price / Cash15.7220.4724.9917.94Price / Book2.004.618.144.63Net Income$1.02B$176.14M$3.24B$993.88M7 Day Performance-0.17%-0.05%1.12%-0.41%1 Month Performance2.04%3.35%8.39%6.46%1 Year Performance-3.11%6.04%34.01%10.83% Alcon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALCAlcon2.6833 of 5 stars$87.21-0.2%$106.13+21.7%-2.9%$43.08B$9.91B38.7625,599DXCMDexCom4.7553 of 5 stars$85.33+2.4%$98.50+15.4%-24.9%$33.46B$4.15B63.6810,300Analyst UpgradeHCAHCA Healthcare4.8535 of 5 stars$380.43+1.2%$395.71+4.0%+12.0%$91.52B$71.59B16.92316,000Upcoming EarningsTHCTenet Healthcare4.74 of 5 stars$177.73+1.1%$184.53+3.8%+31.3%$16.51B$20.67B11.7598,000Upcoming EarningsAnalyst DowngradeEHCEncompass Health4.9256 of 5 stars$119.64+1.0%$131.50+9.9%+28.9%$12.06B$5.37B24.7240,000UHSUniversal Health Services4.9916 of 5 stars$183.49+0.5%$224.77+22.5%-6.5%$11.93B$15.83B10.3099,000Upcoming EarningsDividend AnnouncementENSGThe Ensign Group4.921 of 5 stars$145.75+1.2%$163.50+12.2%+1.0%$8.38B$4.42B27.5539,300Positive NewsUpcoming EarningsACHCAcadia Healthcare4.2612 of 5 stars$24.08-1.1%$47.94+99.1%-66.4%$2.22B$3.15B11.8625,500Positive NewsAnalyst RevisionSEMSelect Medical5 of 5 stars$14.91+1.2%$26.00+74.3%-62.2%$1.92B$5.22B11.1344,100Positive NewsBKDBrookdale Senior Living2.2369 of 5 stars$7.94+0.1%$7.70-3.0%+0.8%$1.86B$3.16B-7.6336,000Analyst DowngradeUSPHU.S. Physical Therapy3.9931 of 5 stars$73.71-1.1%$109.00+47.9%-21.6%$1.12B$671.34M33.817,028High Trading Volume Related Companies and Tools Related Companies DexCom Competitors HCA Healthcare Competitors Tenet Healthcare Competitors Encompass Health Competitors Universal Health Services Competitors The Ensign Group Competitors Acadia Healthcare Competitors Select Medical Competitors Brookdale Senior Living Competitors U.S. Physical Therapy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALC) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alcon Please log in to your account or sign up in order to add this asset to your watchlist. Share Alcon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.